https://rjrindex.com/articles/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma-real-world-evidence-from-the-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cladribine-clad-low-dose-arac-ldac-venetoclax-ven-in-patients-with-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-results-of-sup177sup-lu-nym032 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-and-biomarker-analysis-of-neoadjuvant-chemoradiotherapy-with-or-without-pd-1-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-prospective-phase-ii-study-iputrial-of-inetetamab-and-pyrotinib-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-four-marker-protein-signature-to-predict-ramucirumab-efficacy-in-combination-with-tas-102-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-transanal-vs-laparoscopic-total-mesorectal-excision-on-5-year-overall-survival-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-cetuximab-for-patients-with-locally-advancedmetastatic-chordoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-fih-study-of-cabotamig-a-tce-cdh17-x-cd3-in-cdh17-expressing-gi-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fedratinib-in-patients-with-mdsmpn-and-chronic-neutrophilic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-short-course-intensified-chemotherapy-regimen-nab-pof-in-the-treatment-of-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcome-of-sandwich-therapy-with-induction-chemoimmunotherapy-followed-by-concurrent-chemor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myelodysplasia-related-mutation-dynamics-and-outcomes-in-newly-diagnosed-nd-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-and-racial-disparities-in-car-t-cell-therapy-outcomes-a-national-inpatient-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-in-combination-with-folfox7-and-bevacizumab-evaluation-of-effect-on-oxaliplatin-induced-cip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-detection-five-year-screening-behaviors-and-patient-reported-perceptions-in-detect-a-partici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-circulating-tumor-dna-ctdna-following-liver-resection-in-a-high-risk-population-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-car-t-and-bispecific-antibodies-in-relapsedrefractory-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-or-ivonescimab-plus-axitinib-in-metastatic-mucosal-melanoma-results-from-a-phase-ib-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-activity-of-homoharringtonine-against-melanoma-leptomeningeal-disease-using-patient-deri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-single-arm-muti-center-prospective-clinical-study-of-disitamab-vedotin-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-and-safety-of-syn429-a-synthetic-type-i-ifn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-tp53-pathologic-variants-for-cancer-immunotherapy-using-a-self-replicating-mrna-vaccine-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-stage-matched-genomic-analysis-to-support-molecular-similarity-of-unknown-primary-merkel-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-safety-and-biodistribution-of-sup68sup-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tremelimumab-plus-durvalumab-stride-versus-durvalumab-monotherapy-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-guideline-concordant-adjuvant-chemotherapy-and-survival-outcomes-among-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-prrt-sequencing-after-progression-on-somatostatin-analogue-in-neuroendocrine-tumors-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-a-fak-inhibitor-combined-with-albumin-bound-paclitaxel-and-an-anti-pd-1ctla-4-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogating-acquired-pd-1-resistance-through-bet-bromodomain-inhibition-in-hepatocellular-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-survival-outcomes-in-metastatic-breast-cancer-mbc-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-and-study-design-of-the-kov-hipec-04-a-phase-iii-randomized-controlled-trial-in-primary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noga-neoadjuvant-treatment-optimization-via-mri-guided-de-escalation-in-stage-ii-iii-tnbc-a-phase-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-genetic-susceptibility-to-second-malignant-neoplasms-in-children-and-young-adults-findin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditioning-intensity-and-post-transplant-outcomes-in-acute-myeloid-leukemia-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-combined-with-concurrent-chemoradiotherapy-for-locally-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicaid-expansion-on-survival-across-five-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-artificial-intelligence-ai-as-a-decision-support-tool-in-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-prevalence-of-lung-cancer-screening-and-covariates-among-women-undergoing-breast-cancer-scr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operative-and-non-operative-management-of-small-bowel-obstruction-in-colorectal-cancer-hospitalizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-profile-and-age-distribution-of-breast-cancer-at-a-tertiary-referral-center-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-chemotherapy-with-flot-for-resectable-gastric-and-gastroesophageal-junction-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-remission-after-tyrosine-kinase-inhibitor-cessation-in-chronic-myeloid-leukemia-cml-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-measurable-residual-disease-mrd-rates-in-the-peripheral-blood-and-bone-marrow-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-neighborhood-disadvantage-cannabis-use-and-patient-reported-outcomes-among-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-interruption-and-associated-factors-on-overall-survival-in-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-organ-immune-related-adverse-events-following-immune-checkpoint-inhibitor-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-risk-factors-and-survival-of-secondary-primary-cns-tumors-following-hematologic-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutropenic-diet-nd-versus-liberalized-diet-ld-in-patients-with-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-travel-distance-on-oncologic-outcomes-after-curative-intent-surgery-for-retroperitoneal-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-complementary-anti-cancer-and-analgesic-properties-of-the-natural-product-barettin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicogenomic-profiling-of-mucinous-carcinomas-of-the-gastrointestinal-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-iegfri-subtypes-and-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-cancer-database-analysis-of-hepatoid-adenocarcinoma-epidemiology-socioeconomic-and-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-patient-reported-gynecomastia-following-neoadjuvant-androgen-deprivation-therapy-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-in-advanced-stage-epithelial-ovarian-cancer-implications-for-survivorship-plan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-survival-of-melanoma-in-jordan-2013-2022-a-registry-based-study-of-trends-and-his 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascertain-real-world-asciminib-asc-effectiveness-in-patients-pts-with-philadelphia-chromosome-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-among-us-patients-with-non-muscle-invasive-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mental-health-and-malignancy-real-world-associations-between-early-onset-gastrointestinal-cancers-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-adjuvant-chemotherapy-in-high-risk-stage-ii-colon-cancer-with-microsatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comments-on-the-lunar-trial-in-oligorecurrent-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-clinical-characterization-of-early-onset-gastrointestinal-cancers-integ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-immune-architecture-as-a-predictor-of-response-to-neoadjuvant-chemoradiotherapy-in-rectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abvd-versus-beacopp-for-front-line-treatment-of-hodgkin-lymphoma-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-plus-gemcitabinecisplatin-and-stereotactic-body-radiotherapy-as-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-by-insurance-coverage-in-non-hodgkin-lymphoma-nhl-experience-from-two-academic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-combined-with-anti-pd-1-antibody-as-adjuvant-therapy-for-patients-with-hepatocellular-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-long-term-survival-in-esophageal-carcinoma-is-it-the-same-for-all-stages 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-in-hospital-mortality-among-critically-ill-patients-in-icu-with-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-machine-learning-in-relapsedrefractory-multiple-myeloma-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-interventional-strategies-to-prevent-and-reduce-burnout-in-medical-oncologists-the-resil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-model-prognostic-evaluation-of-immunotherapy-in-advanced-biliary-tract-cancer-and-development 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-preliminary-efficacy-of-a-peer-community-navigator-pcn-led-intervention-for-minori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-first-line-niraparib-maintenance-therapy-in-korean-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-malignant-neoplasms-and-cardiac-arrest-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-camrelizumab-with-chemotherapy-naci-in-pd-l1-negative-locally-advanced-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allostatic-load-neutrophil-to-lymphocyte-ratio-and-body-composition-in-patients-with-metastatic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/online-biographies-of-gynecologic-oncologists-analysis-of-linguistic-differences-based-on-gender-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-eligibility-to-enrollment-evaluating-barriers-to-clinical-trial-participation-for-leiomyosarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/double-lung-transplantation-in-patients-with-metastatic-lung-limited-non-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferences-and-motivations-for-self-collection-hpv-testing-among-cervical-cancer-screening-eligible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-integrated-profiling-of-jak-stat-mapk-and-rtk-ras-signaling-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-resistant-subpopulations-by-profiling-drug-response-heterogeneity-in-patient-derived-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/albumin-bilirubin-index-as-a-determinant-of-short-and-long-term-outcomes-after-locoregional-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctnow-pilot-study-a-multilevel-clinical-trial-education-and-clinical-trial-referral-coordination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-circulating-immunologic-markers-and-hcc-in-individuals-with-chronic-hcv-infecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-acute-care-outcomes-in-metastatic-prostate-cancer-in-a-safety-net-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-machine-learning-for-predicting-immune-checkpoint-inhibitor-associated-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-venetoclax-based-regimens-in-chronic-myelomonocytic-leukemia-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-molecular-landscape-of-biliary-tract-cancers-in-and-near-bronx-ny 2026-08-24 monthly 0.7 https://rjrindex.com/articles/respiratory-failure-in-patients-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-autoimmune-disease-on-clinical-outcomes-in-patients-treated-with-bispecific-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-real-world-validation-of-the-hfa-icos-cardio-oncology-risk-tool-in-her2-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/information-needs-of-breast-cancer-patients-in-a-brazilian-capital-city 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-qls1304-a-novel-highly-potent-and-selective-dual-inhibitor-of-kat6a6b-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-therapy-of-donafenib-in-hepatocellular-carcinoma-with-high-risk-recurrence-fa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/saturn-sts-phase-ii-study-of-neoadjuvant-atezolizumab-with-doxorubicin-concurrent-atezolizumab-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-donafenib-with-or-without-tace-as-postoperative-adjuvant-therapy-for-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbiotax-ttcc-2022-02-a-phase-ii-multicenter-randomized-study-of-cetuximab-with-or-without-week 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-treatment-of-extraskeletal-myxoid-chondrosarcoma-a-retrospective-analysis-of-long-term-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-therapy-in-braf-mutant-melanoma-comparison-of-combination-immunotherapy-anti-ctla4-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stomatitis-as-a-harbinger-of-harm-long-term-mortality-and-multiorgan-adverse-events-associated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-in-relation-to-total-neoadjuvant-therapy-sequence-completion-and-extra-consoli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-associated-with-overall-survival-in-patients-with-merkel-cell-carcinoma-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-incidence-and-mortality-of-liver-cancer-by-etiology-and-sociodemographic-index-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/graft-and-infectious-outcomes-following-immune-checkpoint-inhibitor-exposure-in-kidney-transplant-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-california-end-of-life-option-act-a-case-series-of-77-consecutive-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-age-specific-trends-in-colorectal-cancer-mortality-a-22-year-analysis-of-the-emerging-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-in-colorectal-cancer-mortality-in-south-asia-1990-2023-a-retrospective-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-rna-based-homologous-recombination-deficiency-algorithm-to-predict-first-line-platinum-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quizartinib-in-combination-with-decitabine-and-venetoclax-for-newly-diagnosed-and-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/event-free-survival-from-the-randomized-phase-2-neohip-trial-evaluating-neoadjuvant-taxane-her2-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-nivolumab-plus-ipilimumab-and-adjuvant-nivolumab-in-patients-with-localized-microsatelli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-corticosteroid-timing-paradox-in-immune-checkpoint-inhibitor-treated-solid-tumors-and-its-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-randomized-double-blinded-phase-3-trial-of-vorasidenib-vs-placebo-in-patients-with-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-glp-1-receptor-agonists-ras-on-stage-of-pdac-diagnosis-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-a-highly-selective-fgfr2-inhibitor-3hp-2827-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-durable-response-to-atezolizumab-in-extensive-stage-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-evidence-into-answers-an-agentic-framework-to-support-living-clinical-practice-guideli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iegfri-mutational-landscape-in-non-small-cell-lung-cancer-a-10-year-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-deep-learning-derived-psma-pet-biomarkers-for-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-treating-fields-in-newly-diagnosed-glioblastoma-an-updated-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-in-lung-cancer-survival-outcomes-in-small-cell-and-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-cemiplimab-in-hedgehog-inhibitor-hhi-naive-basal-cell-carcinoma-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-external-beam-radiation-therapy-and-androgen-deprivation-therapy-on-physical-activity-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-risk-of-interstitial-lung-disease-with-dxd-based-versus-non-dxd-trop2-antibody-drug-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-correlates-of-her3-expression-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-trastuzumab-with-or-without-pertuzumab-after-pathologic-complete-response-to-neoadjuvant-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-different-formulations-and-dosing-intervals-of-goserelin-on-testosterone-suppression-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-changes-in-body-composition-during-maximal-androgen-blockade-mab-for-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-in-non-small-cell-lung-cancer-management-in-lebanon-clinical-practices-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-stomach-cancer-attributable-to-alcohol-use-1990-2023-a-comprehensive-epidemiolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laminectomy-versus-laminoplasty-in-the-surgical-management-of-long-segment-intradural-spinal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-population-tumor-kinetics-analysis-for-early-cycle-ctdna-guided-therapy-decisions-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-mutation-longitudinal-dynamics-in-rwd-cohort-of-hrher2-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-large-language-models-for-lung-cancer-patient-education-compared-to-publicly-available-inf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncomovies-cancer-in-cinema-from-early-sound-film-to-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-review-and-meta-analysis-treatment-related-adverse-events-of-neoadjuvant-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twin-survival-calibration-to-enable-cross-disease-interpretation-of-early-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-or-perplexity-assessment-of-discordance-among-different-pd-l1-assays-in-the-same-specimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-of-circulating-nkg7-cytotoxic-cd4-t-cells-as-a-predictor-of-response-to-pd-1-blockade-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalated-chemotherapy-and-endocrine-therapy-outcomes-in-young-women-with-stage-i-hrher2-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-analysis-of-stat6-expression-and-its-relationship-with-tumor-microenvironment-characteris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-with-low-dose-pembrolizumab-plus-chemotherapy-in-early-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-pharmacokinetics-and-resistance-mechanisms-of-tucatinib-in-patients-with-her2mutant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-preliminary-efficacy-of-a-12-week-remotely-delivered-exercise-program-in-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-and-age-related-disparities-with-abemaciclib-responses-in-early-er-positiveher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-squamous-cell-carcinoma-of-the-pancreas-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-circrna-in-modulating-tumor-microenvironment-from-mycobacterial-infection-to-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-pi3k-v-to-develop-novel-combinational-therapies-for-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-cetuximab-plus-immune-checkpoint-inhibitor-ici-versus-cetuximab-plus-carboplatin-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-data-platform-for-comparative-analysis-of-treatment-patterns-costs-and-cost-effective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-atm-in-gastric-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-therapy-in-resectable-pancreatic-cancer-updated-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-neurologic-death-in-nsclc-patients-with-brain-metastases-treated-with-radiosurgery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-to-evaluate-the-safety-tolerability-and-pk-of-eik1005-a-novel-wrn-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-remission-status-in-newly-diagnosed-multiple-myeloma-treated-with-daratumum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-management-of-locally-advanced-pancreatic-cancer-with-arterial-resections-and-reconstructio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-coping-among-early-phase-cancer-clinical-trial-epct-participants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-sarcopenia-and-adiposity-in-prognosis-of-pleural-mesothelioma-a-ct-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escape-to-learn-a-team-based-gamified-educational-experience-for-hematologyoncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematology-oncology-bootcamp-educational-impact-of-an-interactive-guideline-based-101-curriculum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-amivantamab-plus-lazertinib-versus-osimertinib-plus-chemotherapy-for-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-population-based-modular-multi-objective-optimization-framework-with-decoupled-exploration-and-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tarlatamab-in-small-cell-lung-cancer-with-brain-metastases-a-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sinonasal-adverse-events-of-immune-checkpoint-inhibitors-pharmacovigilance-using-faers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/local-delivery-of-sn-38-using-a-biodegradable-implantable-membrane-for-treatment-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volrustomig-monotherapy-for-recurrentmetastatic-hnscc-substudy-2-of-the-evolve-02-phase-2-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caregiver-professional-employment-and-its-impact-on-glioblastoma-patient-survival-results-from-two 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ivonescimab-ak112-a-pd-1vegf-bispecific-antibody-combined-with-nab-paclitaxel-and-ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-tissue-transcriptome-deconvolution-of-grade-associated-tumor-microenvironment-patterns-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolving-landscape-of-chimeric-antigen-receptor-car-t-cell-therapy-for-plasma-cell-leukemia-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidentally-discovered-lung-cancer-in-explanted-lungs-at-the-time-of-lung-transplantation-manageme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-venetoclax-based-therapy-in-t1114-positive-relapsedrefractory-multiple-myeloma-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-gene-set-based-biomarkers-and-therapeutic-targets-for-papillary-thyroid-cancer-based-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lanreotide-for-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-a-korean-populati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-atrial-fibrillation-on-outcomes-of-acute-pulmonary-embolism-in-pancreatic-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-liposomal-irinotecan-in-combination-with-cisplatin-and-bevacizumab-for-high-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-ipilimumab-nivolumab-relatlimab-inr-combination-immunotherapy-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/class-specific-clinical-and-molecular-features-of-ismarca4i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-substructure-dose-signatures-as-predictors-of-late-cardiovascular-events-in-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-electronic-phenotyping-algorithms-for-prostate-cancer-in-all-of-us-and-their-impact-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-patient-reported-outcomes-in-randomized-phase-3-clinical-trials-of-fda-approved-medicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-clinical-utility-of-mri-for-preoperative-staging-of-early-stage-cervical-cancer-in-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-bispecific-rdcadc-theranostic-approach-to-overcome-trastuzumab-deruxtecan-resistance-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-the-effectiveness-of-tepotinib-and-immunotherapy-in-nsclc-with-metex14-skippi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-her2-targeted-tyrosine-kinase-inhibitors-in-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-factors-of-biochemical-recurrence-after-robot-assisted-radical-prostatectomy-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-response-guided-selection-for-hypoxia-directed-major-radiation-de-escalation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-patients-at-risk-for-non-receipt-of-guideline-concordant-treatment-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-validation-study-of-a-novel-biomarker-based-scoring-system-east-score-for-limited-stage-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-fovinaciclib-versus-placebo-combined-with-aromatase-inhibitor-for-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dense-weekly-versus-standard-three-weekly-paclitaxel-in-combination-with-carboplatin-for-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-of-health-on-women-with-early-onset-colorectal-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tme-informed-bioprinted-3d-tissue-model-as-used-to-characterize-architecture-associated-drug-uptake 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-based-differences-in-outcomes-among-small-cell-lung-cancer-patients-treated-with-tarlatamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-disclosure-of-frontline-treatment-1l-tx-with-the-selective-cdk4-inhibitor-bgb-43395-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-treatment-tolerability-of-bria-imt-cpi-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-na-chemoradiotherapy-ctrt-plus-avelumab-ave-in-locally-advanced-rectal-cancer-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-benmelstobart-plus-anlotinib-combined-with-sox-in-the-first-line-treatment-of-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-and-mendelian-randomization-analyses-of-body-mass-index-and-breast-cancer-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-cxcl910-with-pd-l1-and-tmb-as-predictors-of-pembrolizumab-benefit-in-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synovial-sarcoma-misdiagnosis-and-potential-utility-of-ngs-testing-patient-identification-for-autolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-subset-analysis-of-clinical-activity-and-pharmacodynamic-biomarkers-in-patients-with-sarcomas-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-combined-with-garsorasib-in-kras-g12c-mutant-colorectal-cancer-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphopenia-in-breast-cancer-and-association-with-clinical-outcomes-an-analysis-from-over-30000-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epcoritamab-epcor-chemoimmunotherapy-cit-in-patients-pts-with-relapsedrefractory-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-bmi-dependent-overall-survival-differences-in-postmenopausal-breast-cancer-patients-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogeniclikely-pathogenic-plp-variants-in-epithelial-neuroendocrine-neoplasms-the-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-prostate-specific-antigen-cutoff-for-prostate-cancer-detection-a-prospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-onset-inflammatory-bowel-disease-associated-with-immune-checkpoint-inhibitor-therapy-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-egfr-mutant-primary-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-an-mri-derived-recurrence-assay-in-women-with-hormone-receptor-positive-her2-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-cognitive-impairment-after-car-t-therapy-compared-with-autologous-stem-cell-transplantatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-ismad4i-alterations-in-an-immune-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-toxicity-of-bispecific-antibodies-versus-car-t-cell-therapy-in-diffuse-large-b-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/invasive-field-radiotherapy-plus-rituximab-versus-rituximab-alone-after-response-to-immunochemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-single-arm-study-to-evaluate-the-efficacy-of-pembrolizumab-for-leukoplakia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbial-dysbiosis-as-predictor-of-benefit-from-cbm588-as-an-adjunct-to-immune-checkpoint-blockade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-use-and-survival-outcomes-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fraction-genome-altered-to-predict-survival-in-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-early-onset-non-colorectal-cancer-mortality-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noninvasive-detection-of-early-gastric-cancer-via-red-blood-cell-dna-features-associated-with-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-pd-l1-testing-among-persistent-recurrent-or-metastatic-cervical-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-pancreatic-fistula-after-resection-of-pancreatic-neuroendocrine-tumors-incidence-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-group-community-health-worker-led-advance-care-planning-education-on-advance-care-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-older-women-with-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-impact-of-protocol-design-on-enrollment-and-dropout-rates-in-breast-cancer-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-and-functional-profiling-of-galectin-3-in-the-tumor-immune-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-outpatient-car-t-cell-therapy-administration-on-healthcare-utilization-in-patients-with-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-early-onset-metastatic-colorectal-cancer-lt35-years-ras-driven-apctp53-depleted-tmb-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-dynamics-and-prognostic-value-during-first-line-treatment-of-metastatic-colorectal-cancer-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-cisplatin-resistance-in-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-randomized-phase-ii-trial-of-second-line-treatment-for-advanced-soft-tissue-sarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-microbial-signature-as-a-predictor-of-postoperative-colorectal-cancer-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-transcriptomic-signature-to-predict-immune-checkpoint-inhibition-efficacy-in-proficient-mismatch-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-cancer-history-and-perceived-value-of-multi-cancer-early-detection-tests-in-a-national-us-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-combination-of-anlotinib-plus-nab-paclitaxel-and-gemcitabine-ag-as-a-first-line-strategy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tecotabart-vedotin-plus-toripalimab-with-or-without-chemotherapy-as-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-model-protein-set-generation-for-interpretable-serum-proteomics-in-localized-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lumbar-puncture-in-thrombocytopenic-adults-with-leukemia-and-lymphoma-revisited-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-epigenome-wide-associations-and-pre-chemotherapy-prediction-of-post-chemotherapy-inflam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-metabolic-syndrome-associated-mortality-among-patients-with-upper-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-neutrophil-released-myeloperoxidase-in-cancer-associated-cachexia-in-patients-with-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-optical-genome-mapping-ogm-to-identify-atypical-or-cryptic-ikmt2ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-expression-analysis-of-microrna-and-its-associated-gene-network-in-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choosing-wisely-pakistan-a-call-for-value-based-oncology-practice-in-resource-limited-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensity-modulated-proton-therapy-versus-intensity-modulated-photon-radiotherapy-for-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-clinical-characteristics-of-epithelioid-leiomyosarcoma-a-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-chemoembolization-tace-plus-sorafenib-vs-tace-alone-in-the-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-characteristics-of-combined-hepatocellular-cholangiocarcinoma-tumors-in-a-tertiary-care-cent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-skin-toxicity-in-prone-vs-supine-positions-during-preoperative-breast-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognosis-analysis-of-11-patients-with-tfe3-rearranged-perivascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-acral-melanoma-awareness-among-nail-salon-technicians-and-cosmetology-educators-in-califor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-in-a-developing-region-a-five-year-real-world-analysis-from-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-the-decision-for-contralateral-risk-reducing-mastectomy-in-japanese-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-analysis-of-survival-socioeconomic-and-racial-disparities-in-esophageal-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-switching-from-ribociclib-to-palbociclib-due-to-toxicity-in-hormone-receptor-positive-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-signal-dilution-in-cancer-trials-estimation-of-toxicities-through-term-fragmentation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-disease-analysis-of-acute-lymphoblastic-leukemia-in-children-in-africa-incidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-performance-of-large-language-model-derived-and-clinician-documented-ecog-ps-in-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-retinoblastoma-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-aligned-evaluation-of-large-language-models-for-oncology-clinical-decision-support-across-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-ivonescimab-vegfxpd-1-bispecific-antibody-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteolysis-targeting-chimera-protac-targeting-btk-degradation-for-cancer-therapy-in-mantle-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-011-zilovertamab-vedotin-plus-r-chp-versus-polatuzumab-vedotin-plus-r-chp-as-first-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-following-car-t-therapy-in-adults-with-relapsedrefractory-b-all-according-to-prior-inotuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-and-disparities-in-indolent-and-aggressive-non-hodgkin-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-calmangafodipir-in-preventing-chemotherapy-induced-peripheral-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-study-of-sequential-therapy-with-curative-intent-in-de-novo-her2-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-in-association-with-adrenal-insufficiency-in-hospitalized-solid-tumor-patients-on-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-personalized-digital-approach-to-cancer-risk-assessment-in-a-diverse-gynecology-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-implementation-of-a-pilot-prescreening-tool-for-potential-clinical-trial-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosomal-micrornas-and-key-pathways-associated-with-cognitive-impairment-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-burkitt-lymphoma-mortality-in-south-asia-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-perioperative-management-of-inflammatory-myofibroblastic-tumors-at-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-disparities-and-inpatient-outcomes-in-appendiceal-adenocarcinoma-a-us-nationwid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-of-durvalumab-versus-pembrolizumab-in-gastric-cancer-a-propensity-matched-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-expression-signatures-as-predictors-of-prognosis-in-thin-and-thick-primary-cutaneous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oral-medicine-oncology-nexus-periodontal-disease-as-a-predictor-of-survival-and-complications-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levels-of-vegf-a-vegf-c-svegfr-1-and-svegfr-2-in-tumor-tissue-and-serum-of-patients-with-rare-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-chemotherapy-to-checkpoints-survival-trends-in-rectal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-economic-impact-of-modifiable-risk-factors-in-colorectal-cancer-a-comprehensive-analysis-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-real-time-targeted-expert-outreach-model-on-conversion-of-biomarker-results-to-precision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meaning-centered-psychotherapy-versus-dignity-therapy-for-spiritual-well-being-in-patients-with-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-disease-trajectories-not-treatment-timing-as-a-driver-of-outcomes-in-intrahepatic-cholangi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-capecitabine-as-maintenance-therapy-for-metastatic-nasopharyngeal-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-the-association-between-primary-insomnia-and-early-onset-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-trends-in-mortality-with-concurrent-colorectal-cancer-and-chronic-ischemic-heart-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-fgfr2b-and-her2-in-gastric-cancer-implications-for-targeted-therapy-selection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-tad-a-phase-2-single-arm-open-label-study-of-combination-therapy-of-transarteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-and-association-with-autoimmunity-in-immune-checkpoint-inhibitor-ici-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerance-of-gemcitabine-oxaliplatin-gemox-in-advanced-and-metastatic-gallbladder-cancer-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-treatment-of-low-grade-upper-tract-urothelial-carcinoma-lg-utuc-with-padeliporfin-vascul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antigen-switch-and-bcr-axis-enriched-multi-target-car-t-re-infusion-after-prior-car-t-failure-in-rr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-immunotherapy-response-with-direct-acting-antiviral-therapy-in-patients-with-advanced-hepa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-benchmarking-of-us-oncology-populations-and-survival-using-a-multi-health-system-ehr-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-sarcoma-in-syria-a-retrospective-study-from-the-national-referral-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variability-in-higher-education-support-for-adolescents-and-young-adults-with-active-cancer-a-cross 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-hematologyoncology-education-for-physician-trainees-through-an-interactive-online-platfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-quality-improvements-impact-on-colorectal-cancer-screening-among-people-experiencing-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targetable-genomic-alterations-in-early-onset-colorectal-cancer-and-their-therapeutic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-during-and-after-treatment-with-cdk46-inhibitors-for-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-and-deaths-associated-with-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multidisciplinary-biomarker-care-pathway-to-reduce-somatic-sequencing-failure-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-and-cancer-risk-a-review-of-messaging-content-on-websites-of-medical-cancer-government-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multivariate-survival-analysis-and-prevalence-disparities-in-spindle-cell-carcinoma-a-seerstat-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-pericardial-effusion-a-high-risk-marker-for-in-hospital-mortality-and-cardiovascular-coll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-a-vertically-integrated-care-system-on-mortality-risks-in-insured-patients-by-socio-eco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equal-hopes-medicaid-breast-cancer-coordination-of-care-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-profiles-in-hpv-associated-cervical-intraepithelial-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-nuclear-lamina-associated-alterations-as-predictors-of-prostate-cancer-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-and-inflammatory-factors-associated-with-chemotherapy-response-and-survival-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-rna-based-ngs-on-false-positive-fusion-calls-in-colorectal-cancer-compared-with-dna-ngs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sun-protective-behaviours-amongst-indigenous-communities-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-utility-of-comprehensive-genomic-and-transcriptomic-profiling-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-in-previously-treated-advanced-her2-mutant-non-small-cell-lung-cancer-a-single-center-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supportive-care-gaps-during-breast-cancer-treatment-in-vietnam-determinants-and-quality-of-life-cor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cardiovascular-outcomes-among-solid-tumor-adcs-a-tumor-agnostic-observational-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-comparison-of-google-medgemma-and-chatgpt-5-in-expert-reviewed-gastrointesti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/text-based-electronic-patient-reported-outcome-monitoring-in-oncology-a-180-day-longitudinal-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-of-tarlatamab-versus-chemotherapy-ctx-as-second-line-2l-treatment-for-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-conventional-dedifferentiated-and-mesenchymal-chondrosarcoma-a-550-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enabled-multimodal-adjudication-of-revised-imwg-progression-after-bcma-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-treatments-in-patients-with-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-dietary-fiber-and-fructose-with-progression-free-survival-pfs-in-metastaticadvance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-ctdna-dynamics-assessed-by-a-personalized-whole-genome-sequencing-based-assay-as-a-predictor-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-ctdna-as-a-biomarker-of-outcomes-following-stereotactic-body-radiotherapy-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-pandemic-on-breast-cancer-incidence-and-immunohistochemical-subtype-distribution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-of-ductal-carcinoma-in-situ-a-large-south-american-multicenter-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/middle-high-altitude-residence-as-a-predictor-of-improved-immune-checkpoint-inhibitor-outcomes-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-actionable-turbt-derived-bladder-cancer-organoid-pharmacotyping-as-a-predictor-of-postope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histochrome-virtual-multiplex-immunohistochemistry-from-routine-hampe-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-models-as-decision-support-in-the-absence-of-genomic-profiling-a-simulated-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-ultra-low-psa-after-3-and-6-months-of-intensified-androgen-deprivation-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observation-versus-maintenance-pd-1-inhibitor-therapy-after-clinical-complete-response-in-dmmrmsi-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obese-patients-with-non-small-cell-lung-carcinoma-and-the-intratumor-microbiome-and-immune-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-circulating-tumor-dna-in-pancreatic-ductal-adenocarcinoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-support-for-treatment-of-patients-with-glioblastoma-a-systems-biology-approach-enabled-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-pet-rano-10-criteria-and-associations-with-outcome-in-iidh-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-hb0025-a-pd-l1vegf-bispecific-antibody-in-combination-with-chemotherapy-as-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-event-severity-and-clinical-outcomes-with-immune-checkpoint-inhibitor-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-neoantigen-vaccine-as-adjuvant-therapy-in-high-risk-postoperative-esophageal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-level-association-between-age-enriched-populations-and-treatment-effect-in-frontline-randomize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-and-role-in-guiding-individualized-treatment-of-imaging-extranodal-extension-iene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-immune-checkpoint-inhibition-and-dendritic-cell-vaccination-in-advanced-pleural-and-perito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-spatial-tumor-microenvironment-analysis-in-metastatic-microsatellite-stable-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-of-biweekly-compared-with-standard-triweekly-gemcitabinenab-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-outcomes-of-early-onset-pancreatic-cancer-10-year-retrospective-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-centralized-app-led-peer-to-peer-program-on-patient-access-provider-burden-and-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-clearance-of-adjuvant-chemotherapy-in-localized-colorectal-cancer-using-an-ult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-after-pre-biopsy-steroid-administration-in-primary-cns-high-grade-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-integrating-early-palliative-care-in-advanced-sarcoma-patients-for-enhanced-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpm1i-co-mutation-on-post-transplant-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-central-review-process-on-response-rates-in-neuroblastoma-clinical-trials-a-report-from-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-from-a-real-world-study-association-of-cdcp1-expression-level-with-survival-outcomes-in-mcrc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-migration-patterns-of-practicing-medical-oncologists-in-the-united-states-2020-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prophylactic-cyclophosphamide-on-alc-and-delayed-neurotoxicity-after-cilta-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-and-safety-of-trastuzumab-deruxtecan-in-her2-positive-and-her2-low-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-covid-19-mrna-vaccination-on-bispecific-antibody-outcomes-in-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-zn-a-1041-a-highly-blood-brain-barrier-bbb-permeable-her2-tyrosine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-prediction-models-for-familial-breast-cancer-a-cochrane-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-pulmonary-nodules-across-latin-america-a-real-world-observational-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cell-type-specific-circadian-disruption-in-pediatric-b-all-on-clock-based-biomarkers-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-oncologic-outcomes-in-patients-with-triple-negative-tn-lobular-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardized-mean-differences-of-primary-outcomes-found-in-randomized-controlled-trials-of-wellness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-to-identify-stroma-based-prognostic-groups-in-oncogene-addicted-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-of-gfh375-in-patients-with-advanced-cholangiocarcinoma-or-colorectal-cancer-har 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-for-triple-negative-breast-cancer-in-brazil-a-call-for-public-health-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-safety-of-axicabtagene-ciloleucel-versus-lisocabtagene-maraleucel-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-mortality-among-us-adults-aged-55-before-and-after-the-introduction-of-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prag-50-personalized-thymosin-alpha-1-and-radioimmunotherapy-for-advanced-refractory-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-foundation-model-as-a-predictor-of-efficacy-of-next-generation-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-sintilimab-combined-with-nab-paclitaxel-and-s-1-as-first-line-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-molecular-and-clinical-features-of-systemic-cancers-that-spread-to-the-intradural-spi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quiet-crisis-pancreatic-cancer-incidence-mortality-and-dalys-in-latin-america-and-the-caribbean 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-cohort-validation-of-a-semaphorin-prognostic-signature-to-identify-an-immune-excluded-subtype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognition-of-apalutamide-adt-treatment-responders-versus-non-responders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-first-line-etcdk46i-continuation-beyond-disease-progression-in-a-large-cohort-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-prostate-specific-antigen-psa-decline-among-the-latin-american-subgroup-of-libertas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cetuximab-irinotecan-rechallenge-versus-regorafenib-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-small-cell-lung-cancer-and-the-obesity-paradox-a-retrospective-cohort-study-using-the-trinetx-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvotatug-vedotin-sv-an-investigational-integrin-beta-6-ib6directed-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-single-center-single-arm-trial-of-r-isv-folactis-in-situ-vaccination-for-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-hampe-images-to-predict-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-analysis-of-phase-i-and-expanded-access-study-cohorts-of-doc1021-dubodencel-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-prophylactic-anticoagulation-in-patients-with-multiple-myeloma-receiving-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/turning-clinically-approved-parp-inhibitors-into-immunotherapy-sensitizers-by-reprogramming-the-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-etiologic-burden-of-hepatocellular-carcinoma-hospitalizations-in-the-united-states-2016-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-serum-folate-receptor-alpha-levels-in-colon-cancer-association-with-diagnosis-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-tsn1611-a-highly-selective-oral-kras-g12d-inhibitor-in-solid-tumors-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-aps03118-a-next-generation-ret-inhibitor-in-patients-with-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-based-signatures-of-nucleosome-organization-to-enable-prostate-cancer-subtyping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-androgen-receptor-pathway-inhibition-for-patients-with-high-risk-localized-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-red-blood-cell-distribution-width-to-albumin-ratio-and-incident-cancer-risk-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/satmm-a-systems-genetic-network-analysis-based-risk-stratification-tool-validated-across-the-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-vedolizumab-to-facilitate-use-of-immune-checkpoint-inhibitors-in-cancer-patients-at-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-black-patients-with-newly-diagnosed-multiple-myeloma-in-the-era-of-triplet-and-q 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lap-net1-results-of-a-phase-1b-evaluating-np137-an-inhibitor-of-the-epithelial-to-mesenchymal-tran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-molecular-subtypes-mutational-features-and-circulating-tumor-dna-dynamics-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-income-related-lung-cancer-disparities-since-the-introduction-of-uspstf-screening-guidelin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-safety-and-patient-reported-quality-of-life-with-first-line-chemotherapy-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-data-from-rosetta-lung-02-a-global-randomized-phase-23-trial-of-pumitamig-pd-l1-vegf-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-among-caregivers-of-patients-with-breast-cancer-in-mexico-a-multicenter-cross-secti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-germline-genetic-testing-of-patients-with-hematologic-malignancies-to-identify-high-proport 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-covid-19-pandemic-on-breast-cancer-stage-at-time-of-diagnosis-at-a-major-health-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-identify-racial-and-socioeconomic-disparities-in-the-onset-and-tumor-distributio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-in-the-era-of-systemic-immunotherapy-for-bcg-naive-high-risk-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-trial-of-a-psychosocial-digital-application-thrive-mm-for-patients-living-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-nivo-ipi-as-first-line-1l-treatment-for-patients-with-metastatic-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-with-fruquintinib-plus-sintilimab-versus-axitinib-or-everolimus-in-advanced-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-a-neoadjuvant-21-gene-breast-recurrence-score-assay-to-redirect-surgical-and-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/direct-oral-anticoagulants-versus-low-molecular-weight-heparin-for-venous-thromboembolism-in-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ripretinib-as-preoperative-therapy-in-patients-with-potentially-resectable-advanced-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-versus-adjuvant-chemotherapy-in-cardiac-tumor-resection-a-propensity-matched-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-during-and-after-multimodal-treatment-for-resectable-esophageal-aden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ibii-study-of-trastuzumab-deruxtecan-combined-with-nivolumab-and-capox-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-atlas-of-peripheral-blood-immune-landscape-in-pmmrmss-rectal-cancer-treated-with-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-anti-epcam-x-anti-cd3-bispecific-antibody-m701-for-the-treatment-of-malignant-pleural-effusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-btae-haic-combined-with-lenvatinib-and-camrelizumab-for-patients-with-high-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-role-of-ifitm3-and-the-pi3kakt-axis-in-the-acute-myeloid-leukemia-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-ii-trial-of-nivolumab-and-ipilimumab-in-children-and-young-adults-with-relapsed-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-prophylaxis-in-non-small-cell-lung-cancer-patients-patients-with-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-adjuvant-braf-and-mek-inhibition-with-dabrafenib-and-trametinib-in-braf-v600k-compared-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-lung-cancer-among-patients-with-idiopathic-interstitial-lung-disease-a-cohort-study-using-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-it-pd-1ctla-4-antibody-combined-with-pemetrexed-pm-for-leptomeningeal-metastases-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sglt-2-inhibitors-more-than-glycemic-control-in-diabetic-patients-with-renal-cell-carcinoma-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-clinical-yield-of-serial-large-ngs-panel-liquid-biopsies-in-routine-care-analysis-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-deletions-and-co-mutational-landscape-from-whole-genome-sequencing-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-l1-plus-chemotherapy-in-advanced-pd-l1-negative-nonsquamous-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploiting-ribosomal-biogenesis-dependence-through-rna-polymerase-i-inhibition-in-medulloblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-agnostic-and-cross-indication-actionable-alterations-in-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/different-roles-of-sall4-and-oct34-in-the-development-and-evolving-processes-of-benign-and-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nationwide-population-based-study-on-the-incidence-and-prognosis-of-patients-with-her2-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adjuvant-anti-pd-1anti-pd-l1-immunotherapy-in-resected-renal-cell-carcinoma-rcc-an-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-ai-driven-pan-cancer-pre-screening-of-actionable-gene-fusions-from-hampe-slides-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-regional-disparities-in-prostate-cancer-associated-dementia-mortality-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/denosumab-as-an-immune-modulator-results-of-a-window-of-opportunity-study-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-ipilimumab-nivo-ipi-vs-nivo-in-microsatellite-instability-highmismatch-repair-defic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-human-epidermal-growth-factor-receptor-2-her2-amplified-and-her2-mutated-left 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cladribinecyclophosphamide-lymphodepletion-efficacy-and-toxicity-in-cd19-car-t-therapy-for-b-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-landscape-of-osteosarcoma-systematic-review-and-analysis-of-1058-patients-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-progression-free-survival-pfs-with-microsatellite-instability-high-msi-h-or-misma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-warburg-effect-mitochondrial-metabolic-modulation-with-intermittent-fasting-during-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protective-factors-supporting-caregiver-well-being-in-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sparto-a-phase-i-study-of-pd-1-inhibitor-spartalizumab-pdr001-in-combination-with-low-dose-of-paz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-activity-of-amivantamab-by-consensus-molecular-subtypes-in-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-olverembatinib-hqp1351-in-patients-with-chronic-phase-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mc240701-decentralized-pilot-study-of-triple-oral-metronomic-chemotherapy-in-recurrentmetastatic-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-dc-personalized-neoantigen-dendritic-cell-vaccine-pilot-trial-for-high-risk-triple-negati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fierce-hn-a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-of-ficlatuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-clinical-study-of-neoadjuvant-combination-of-axitinib-plus-torip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sup111sup-in-xyimsr-01-spect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-variation-in-outcomes-and-resource-utilization-among-us-hospitalizations-for-tumor-lysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiota-prognostic-signature-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-or-targeted-therapy-real-world-comparative-outcomes-in-advanced-and-recurrent-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-and-urban-disparities-in-cancer-mortality-in-texas-during-the-covid-19-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortalities-due-to-pneumonitis-in-esophageal-cancer-in-the-united-states-1999-2020-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-disability-adjusted-life-years-from-hepatitis-c-related-liver-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-covid-changes-to-healthcare-utilization-expenditures-and-care-prioritization-among-us-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-flexible-and-adapted-follow-up-strategies-in-a-patient-centric-phase-ii-trial-of-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-profiles-of-frontline-btk-inhibitor-containing-regimens-in-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-inpatient-burden-of-nausea-vomiting-and-dehydration-during-radiotherapy-a-hcup-nis-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xerostomia-following-lutetium-177-psma-radioligand-therapy-in-metastatic-prostate-cancer-associatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-clinicians-empathy-association-with-mean-number-of-visits-and-referrals-to-psychosocial-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronic-condition-cost-burden-among-older-medicare-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-by-socioeconomic-characteristics-among-younger-adults-hospitalized-with-gastroint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-chronic-pain-depression-and-social-vulnerability-in-us-adults-with-colon-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishing-a-rapid-diagnostic-clinic-at-a-tertiary-care-cancer-center-the-indiana-university-simo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-spatial-distribution-of-high-risk-prostate-cancer-patterns-evaluation-on-digital-patho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anthracycline-free-vs-anthracycline-containing-dual-anti-her2-neoadjuvant-therapy-real-world-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-evaluation-of-a-multidisciplinary-lung-cancer-early-detection-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-differences-between-primary-and-metastatic-melanoma-insights-from-aacr-genie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-endometrial-cancer-surgery-on-the-development-of-cardiovascular-risk-factors-in-women-unde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-idpydi-genotyping-in-response-to-fda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-as-high-acuity-phenotypes-in-us-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-stratification-and-actionable-genomic-alterations-in-endometrial-carcinoma-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-neoadjuvant-endocrine-therapy-versus-chemotherapy-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-significant-immune-related-adverse-events-with-perioperative-pembrolizumab-in-early-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-targeted-tumor-genomic-profiles-in-prostate-cancer-among-black-and-white-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bladder-cancer-journey-using-a-social-media-campaign-to-uncover-educational-needs-of-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymph-node-ratio-in-relation-to-the-survival-benefit-of-immediate-breast-reconstruction-in-node-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-analysis-of-high-dose-rate-brachytherapy-combined-with-total-neoadjuvant-therapy-versus-tot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-dna-and-rna-next-generation-sequencing-ngs-for-accurate-diagnosis-dx-and-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-maternal-outcomes-among-pregnant-patients-with-cancer-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-of-recurrentmetastatic-platinum-resistant-nasopharyngeal-cancer-patients-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-to-identify-hdl-as-a-prognostic-factor-for-melanoma-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-avoidable-observation-stays-in-cancer-patients-requiring-procedural-interventions-through-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-endometrial-cancer-subsets-ipolei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pathologic-necrosis-on-clinical-outcomes-following-neoadjuvant-radiation-for-soft-tissue-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropathy-following-chimeric-antigen-receptor-t-cell-therapy-incidence-and-associated-risk-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genotype-anatomic-correlates-and-survival-outcomes-in-a-molecularly-validated-90-patient-cohort-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-acute-complications-in-gastrointestinal-cancer-hospitalizations-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-agent-ai-platform-for-clinical-trial-operations-specialized-agents-to-accelerate-feasibilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproductive-outcomes-after-chemotherapy-in-young-women-with-non-hodgkin-lymphoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smoking-prevalence-as-a-predictor-of-preventable-cancer-burden-a-mediation-analysis-with-health-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-based-combinations-for-waldenstrom-macroglobulinemia-real-world-experience-from-a-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanical-ventilation-timing-categories-and-inpatient-outcomes-in-adult-cancer-hospitalizations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-istreptococcus-anginosusi-with-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/on-the-borderline-gej-coding-as-a-driver-for-stage-migration-and-survival-difference-a-seer-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-disparities-in-catastrophic-health-expenditures-among-cancer-survivors-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-cells-with-pd-l1-expression-and-clusters-in-confirmative-tumor-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-azd6750-a-cd8-guided-interleukin-2-agent-alone-and-in-combination-with-other-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-ferroptosis-score-activity-as-a-predictor-of-survival-and-rituximab-response-in-diffuse-large-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-oncology-clinical-trials-in-africa-over-the-last-three-decades-1995-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-integrated-rehabilitation-and-risk-of-distant-metastases-in-breast-cancer-patients-a-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-carboplatin-paclitaxel-cp-for-metastatic-anal-squamous-cell-carcinoma-ascc-an-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-flag-based-versus-standard-37-induction-therapy-in-adults-with-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intelligence-driven-data-extraction-for-the-breast-cancer-multidisciplinary-team-meeting-case-prepar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-frailty-among-hospitalized-patients-with-acute-myeloid-leukemia-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-incidence-and-stage-at-presentation-of-hepatocellular-carcinoma-a-seer-based-study-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analgesia-profile-and-racial-disparity-in-opioid-use-among-cancer-patients-hospitalized-in-a-public 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-mortality-in-adults-with-liver-and-intrahepatic-bile-duct-malignancies-a-25-year-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-patient-outcomes-and-tumor-genetics-in-perinatal-early-onset-colorectal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-cancer-drug-indication-pairs-recommended-for-funding-on-the-australian-pharmaceut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-recurrence-after-perioperative-flot-for-resectable-gastric-cancer-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/g8-geriatric-score-as-a-determinant-of-survival-and-treatment-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-international-multicenter-randomized-controlled-trial-of-selective-index-lymph-node-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-palliative-care-delivery-in-oncology-in-a-resource-constrained-setting-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-prognostic-value-of-ctdna-monitoring-among-advanced-breast-cancer-with-oligo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dental-prophylaxis-on-long-term-systemic-risks-in-therapy-induced-oral-mucositis-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/womens-perceptions-and-preferences-regarding-liquid-biopsy-for-breast-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-tolerability-and-outcomes-of-generic-palbociclib-in-metastatic-hr-positive-her2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-colon-cancer-patients-with-autism-spectrum-disorder-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-lung-metastasis-in-pediatric-and-young-adult-differentiated-thyroid-cancer-a-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-early-onset-cancers-in-hungary-nationwide-trends-in-incidence-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-antifungal-prophylaxis-in-acute-myeloid-leukemia-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-manual-chart-review-in-oncology-validation-of-an-ai-based-monitoring-tool-for-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-progression-free-and-overall-survival-from-response-endpoints-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/convergent-pi3k-pathway-activation-and-swisnf-dysfunction-as-characteristics-of-bone-metastatic-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-mediated-toxicities-iraes-in-immune-checkpoint-inhibitor-ici-therapy-in-various-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-awareness-to-enrollment-gap-an-assessment-of-oncologist-barriers-in-clinical-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flt3-inhibitors-across-the-allogeneic-transplant-continuum-in-iflt3i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrna-profiles-to-identify-metaphase-histone-and-cancer-testis-antigen-gene-overexpression-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-study-of-ivonescimab-in-combination-with-folfox-in-advanced-her2-negative-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-temab-a-plus-osimertinib-osi-as-1l-treatment-for-unresectablemetastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-urine-liquid-biopsy-in-detecting-of-clinically-relevant-genomic-alterations-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-occupational-mesothelioma-in-brazil-2007-2024-a-comparative-analysis-between-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-delivery-of-tobacco-treatment-in-oncology-care-moving-the-needle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-sequential-chemoradiotherapy-on-long-term-overall-survival-in-early-stage-cervica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-therapy-with-bcg-response-in-high-risk-non-muscle-invasive-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intismeran-autogene-plus-pembrolizumab-versus-pembrolizumab-alone-in-high-risk-resected-melanoma-5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-diagnosed-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bulumtatug-fuvedotin-bfv-9mw2821-plus-toripalimab-in-patients-with-locally-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-exceed-a-phase-1-study-of-ly4101174-an-antibody-drug-conjugate-targeting-nect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-molecular-signatures-in-colorectal-cancer-directly-from-routine-whole-slide-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp-1-receptor-agonists-in-hormone-receptor-positive-breast-cancer-patients-receiving-cdk4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-baseline-serotonergic-antidepressant-use-on-survival-and-immune-related-adverse-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-characteristics-associated-with-non-durable-response-to-first-line-immunotherapy-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-following-tumor-infiltrating-lymphocyte-til-therapy-with-commercial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-targeting-of-lung-cancer-using-the-anti-p329g-adapter-car-t-cell-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipredict-phase-ii-study-of-cd8-pet-in-patients-with-immunoresponsive-solid-tumors-imaging-character 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-consensus-based-feature-selection-on-machine-learning-performance-for-metastatic-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-data-disclosure-from-the-first-in-human-phase-12-trial-of-smp-3124lp-the-first-investigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-mortality-across-gastrointestinal-malignancies-by-hospital-structural-characteristics-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidity-related-medical-expenditures-and-health-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-pd1pdl1-inhibitor-based-regimens-in-unresectable-stage-iiib-iiic-and-iv-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synthetic-data-generation-from-breast-cancer-patients-to-enable-psm-on-wide-and-multidimensional-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-immune-checkpoint-inhibitor-anti-vegf-inhibitor-combinations-in-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preparedness-of-internal-medicine-residents-for-oncologic-emergencies-and-end-of-life-discussions-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-us-pneumonia-related-admissions-among-patients-with-multiple-myeloma-2006-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-identification-of-patients-at-risk-for-early-infectious-complications-after-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-from-the-trinetx-database-comparing-abiraterone-versus-darolutamide-in-hormone-sensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-cetuximab-monotherapy-following-pd-1-inhibitor-treatments-in-patients-with-recurrentmet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-dynamics-following-molecularly-targeted-therapy-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-from-a-first-in-human-phase-12-study-of-askg915-an-anti-pd-1pro-il-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronotherapy-in-metastatic-non-small-cell-lung-cancer-clinical-outcomes-according-to-immune-checkp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-hepatocellular-carcinoma-vs-intrahepatic-cholangiocarcinoma-related-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-efficacy-of-first-line-necitumumab-plus-pembrolizumab-in-pd-l1-high-advanced-nsclc-final-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-gastrointestinal-malignancies-in-hiv-the-impact-of-opportunistic-and-non-opportunistic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-thymic-epithelial-tumors-tets-with-lynch-syndrome-ls-per-germline-genetic-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-adjuvant-capecitabine-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-pretreatment-vitamin-d-insufficiency-in-racial-disparity-in-taxane-induced-peripheral-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-deep-learning-for-neuro-oncology-knowledge-distilled-efficientnetb0-powered-mri-classificat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiotoxicity-with-chimeric-antigen-receptor-t-cell-car-t-therapy-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-act001-combined-with-radiotherapy-in-newly-diagnosed-pediatric-diffuse-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-ismarca4i-mutant-versus-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-in-recurrent-glioblastoma-real-world-outcomes-from-a-colombian-cohort-regoma-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-istk11i-ikeap1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-treatment-interaction-modeling-to-identify-temozolomide-sensitive-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-intestinal-irradiation-to-enhance-the-efficacy-and-prognosis-of-pd-1-blockade-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-investigator-initiated-phase-i-study-evaluating-the-safety-tolerability-and-preliminary-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-toxicities-associated-with-sulfamethoxazoletrimethoprim-tmp-smx-for-pneumocys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-therapy-and-risk-of-small-intestinal-neoplasms-real-world-evidence-from-a-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-associated-with-tarlatamab-for-extensive-stage-small-cell-lung-cancer-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-determinants-in-procured-melanoma-tissue-as-drivers-of-durable-response-to-tumor-infiltr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-muscle-invasive-and-metastatic-bladder-and-urethral-pure-adenocarcinoma-buad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-profile-and-progression-patterns-in-lung-squamous-cell-carcinoma-treated-with-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-albumin-as-an-early-predictor-of-survival-in-patients-receiving-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-microenvironment-msi-status-and-tumor-mutational-burden-as-prognostic-factors-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-cystectomy-vs-bladder-sparing-therapy-in-very-high-risk-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-volumetric-and-radiomic-mri-brain-analysis-for-prognostication-and-treatment-response-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-safe-pre-chemotherapy-absolute-neutrophil-count-thresholds-in-early-stage-breast-and-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-tumor-stroma-crosstalk-with-icam1-antibody-drug-conjugates-to-enable-dual-compartment-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-responses-in-recurrent-respiratory-papillomatosis-patients-treated-with-dna-immunotherapy-ino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-3-year-landmark-overall-survival-analysis-of-rp1-plus-nivolumab-in-patients-with-anti-pd-1-failed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-patients-with-extensive-stage-small-cell-lung-cancer-treated-with-durvalumab-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-lego-as-a-constructivist-teaching-tool-in-undergraduate-and-patient-education-of-cancer-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-anti-pd-1-prolgolimab-monotherapy-in-resectable-high-risk-melanoma-pathologic-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-bone-marrow-biopsy-bmbx-performance-relative-to-a-mastery-level-standard-a-sim-bmbx-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pathology-based-model-for-postoperative-recurrence-or-metastasis-prediction-and-adjuvant-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bc3195-a-novel-adc-targeting-cadherin-3-cdh3-preliminary-results-of-a-phase-i-study-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratos-p-clinical-model-for-prognosis-and-selection-of-patients-with-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-dkrd-versus-dvrd-regimens-in-multiple-myeloma-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-on-treatment-dose-adjustments-on-the-efficacy-of-enfortumab-vedotin-and-pembrolizumab-evp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-recurrence-on-neoadjuvant-chemo-immunotherapy-ncit-in-patients-pts-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-to-identify-health-system-levers-for-survival-outcomes-of-patients-wi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-due-to-coexisting-respiratory-infections-and-multiple-myeloma-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-in-the-united-states-and-india-an-international-collaborative-study-comparing-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-response-relationship-of-serum-iron-ferritin-and-transferrin-saturation-with-cancer-related-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mc1923-phase-ii-durvalumab-plus-lurbinectedin-in-platinum-resistant-relapsed-extensive-stage-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-effect-of-neoadjuvant-chemotherapy-in-gbrca-mutated-compared-to-gbrca-wild-type-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-circulating-small-extracellular-vesicle-associated-mirna-in-head-and-neck-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-burden-and-distribution-of-febrile-neutropenia-among-hospitalizations-with-pancreatic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-breast-cancer-a-systematic-landscape-analysis-of-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonist-use-in-lung-cancer-patients-receiving-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gk01-stemness-enriched-tumor-reactive-t-cell-therapy-plus-il-2-in-advanced-solid-tumors-orr-and-clo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-for-pancreatic-cancer-diagnosis-efficientnet-based-deep-learning-for-stage-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-small-extracellular-vesicle-protein-based-model-for-ovarian-cancer-relapse-detection-and-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-and-cachexia-as-drivers-of-failure-to-rescue-in-gynecologic-cancer-hospitalizations-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-patients-pts-with-synchronous-versus-metachronous-metastatic-urothelial-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-treatment-patterns-and-outcomes-among-patients-pts-with-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primal-precision-randomized-clinical-trial-comparing-mtb-assisted-care-to-usual-care-quality-of-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-spatial-analysis-of-tumor-microenvironment-during-neuroendocrine-ne-transformation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-powered-human-in-the-loop-real-time-registry-platform-to-enable-clinical-trials-pragmatic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-ii-trial-of-atezolizumab-plus-carboplatin-and-etoposide-for-extensive-stage-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-sintilimab-combined-with-nab-paclitaxel-in-the-treatment-of-platinum-resistant-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everolimus-and-aromatase-inhibitors-for-advanced-and-recurrent-low-grade-serous-ovarian-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/has-racial-and-ethnic-representation-in-oncology-clinical-trials-changed-a-30-year-systematic-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-mri-surveillance-after-breast-cancer-in-the-context-of-persistent-racial-disparities-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-department-visits-and-hospitalizations-in-cancer-survivors-with-disabilities-a-national-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-in-vivo-car-t-cell-generation-using-a-cd8-targeted-lipid-nanoparticle-platform-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-the-post-covalent-bruton-tyrosine-kinase-inhibitor-cbtki-landscape-in-mantle-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zamboni-a-phase-ii-study-of-zanzalintinib-for-metastatic-clear-cell-renal-cell-carcinoma-with-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-omaha-u01-substudy-01a-oral-steroidogenesis-inhibitor-opevesostat-alone-or-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12a-multicenter-first-in-human-open-label-clinical-trial-evaluating-mdx2004-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-induction-chemoimmunotherapy-ici-with-cemiplimab-in-combination-with-cisplatin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-decades-of-population-based-cancer-incidence-trends-in-costa-rica-implications-for-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-treatment-based-algorithm-to-infer-biomarker-status-in-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interventions-to-improve-hope-and-psychosocial-outcomes-in-patients-with-advanced-solid-tumor-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-response-to-pro-emt-effects-of-type-2-diabetic-exosomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-comparison-of-patient-derived-organoid-drug-screening-with-standard-guideline-recommenda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-xenograft-alignment-with-patient-tumors-to-inform-treatment-studies-in-uterine-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-perceptions-and-barriers-to-palliative-care-in-pakistan-a-narrative-synthesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-landscape-and-survival-outcomes-in-gastric-adenocarcinoma-a-hispaniclatino-cohort-from-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-fatigue-associated-with-immunotherapeutics-analyzing-patterns-and-associated-factors-during-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tacehaic-combined-with-bevacizumab-and-tislelizumab-as-third-line-therapy-for-colorectal-cancer-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-pembrolizumab-plus-chemotherapy-in-advanced-triple-negative-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-primary-thromboprophylaxis-in-adult-ambulatory-cancer-patients-a-scholarly-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-detection-with-a-multiomic-liquid-biopsy-comparing-and-combining-blood-and-stool 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-mortality-and-resource-utilization-with-acute-complications-among-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitors-on-the-pathological-complete-response-rate-in-luminal-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-a-resident-led-elective-to-improve-the-understanding-of-cancer-prevention-and-survivorship 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-response-and-safety-profile-of-axatilimab-in-chronic-gvhd-pooled-analysis-of-384-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imatinib-related-toxicity-profile-in-patients-with-gastrointestinal-stromal-tumors-seen-over-a-twent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-nrg1her3-axis-to-overcome-therapy-resistance-in-head-and-neck-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-recognition-and-assessment-through-non-invasive-evaluation-crane-a-prospective-clinical-va 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-use-of-a-community-based-narrative-resource-to-support-psychosocial-care-in-aya 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-cancer-specific-survival-analysis-by-hpv-status-in-oropharyngeal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antihistamine-use-and-immune-checkpoint-inhibitor-efficacy-an-institutional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-distinction-between-ici-induced-psoriasis-vulgaris-and-psoriasiform-dermatitis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-angiotensin-receptor-neprilysin-inhibitor-arni-for-prevention-of-cancer-therapy-relate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cardio-oncologic-burden-leukemia-associated-arrhythmia-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-phst001-an-anti-cd24-monoclonal-antibody-in-adult-patients-with-advanced-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-analysis-of-facility-level-survival-differences-in-elderly-splenic-marginal-zone-lymphoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-the-risk-of-hematologic-adverse-events-in-hrher2-breast-cancer-patients-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-in-patients-receiving-immune-checkpoint-inhibitors-incidence-risk-factors-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-study-re-evaluating-follow-up-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melody-a-prospective-non-interventional-multicenter-cohort-study-to-evaluate-different-imaging-guid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-urothelial03-a-phase-23-study-of-datopotamab-deruxtecan-dato-dxd-platinum-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-care-and-survival-outcomes-in-older-adults-with-chronic-lymphocytic-leukemiasmall-lymphoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-gucg-2238-deescalate-a-pragmatic-trial-to-revisit-intermittent-androgen-deprivation-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-multi-center-trial-of-rpt1g-in-patients-with-relapsedrefractory-acute-myeloid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-introducing-cemiplimab-as-adjuvant-treatment-in-high-risk-cutaneous-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-ibrca12i-pathogenic-variants-homologous-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-resident-learning-in-anticoagulation-management-a-single-institution-quality-improvement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-drivers-of-early-readmission-in-cancer-patients-to-improve-care-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-doxorubicin-plus-trabectedin-dt-in-leiomyosarcoma-lms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-quality-outcomes-following-implementation-of-a-comprehensive-care-program-in-community-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-clinical-presentation-and-survival-in-early-onset-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-actionable-biomarkers-and-treatment-patterns-in-early-onset-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-and-pragmatism-clinical-and-public-health-implications-of-multi-cancer-early-detection-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-iesr1i-mutation-status-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-in-squamous-cell-carcinoma-of-the-vulva-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-guided-microsatellite-instability-classification-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-an-integrated-aging-assessment-for-cancer-patients-in-oncology-clinics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-intratumoral-oncolytic-vv1-plus-cemiplimab-simons-stage-1-results-from-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genotype-directed-targeted-therapy-combined-with-haic-and-tislelizumab-for-microsatellite-stable-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparable-clinical-efficacy-of-pyrotinib-in-trastuzumab-naive-and-trastuzumab-exposed-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivermectin-use-in-patients-with-cancer-over-the-past-decade-at-an-academic-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-bevacizumab-and-chemotherapy-as-second-line-therapy-in-pd-l1-positive-ras-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-timing-a-retrospective-analysis-of-short-course-tki-induction-and-survival-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-patterns-among-patient-reported-adverse-events-in-advanced-nsclc-a-post-hoc-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-31-gene-expression-profile-for-identification-of-real-world-node-negative-patients-with-stage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-urine-based-hpv-testing-for-cervical-neoplasia-and-cancer-a-landmark-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-left-ventricular-thrombus-in-hospitalized-oncology-patients-national-burden-and-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-and-enhancement-of-the-proacct-model-for-predicting-30-day-acute-care-events-following-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-figo-2018-cervical-cancer-staging-system-need-revision-insights-from-a-global-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sociodemographic-factors-on-molecular-testing-patterns-in-localized-and-metastatic-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-us-real-world-study-of-second-line-outcomes-in-advanced-ovarian-cancer-by-first-line-parp-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-palliative-care-referral-and-overall-survival-in-patients-with-melanoma-brain-metastases-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-patterns-of-irae-onset-by-treatment-regimen-and-organ-system-in-a-pan-cancer-ici-treated-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-to-assess-the-safety-and-efficacy-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-intraperitoneal-dehydration-hyperthermia-and-chemotherapy-in-an-in-vitro-model-of-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-vs-5-alpha-reductase-inhibitors-for-prostate-cancer-primary-prevention-in-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-of-osimertinib-in-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognostic-analysis-of-epidermal-growth-factor-receptor-mutated-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-hotspot-specific-chemotherapy-resistance-patterns-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/velzatinib-idrx-42-as-1l-or-2l-therapy-for-advanced-gastrointestinal-stromal-tumors-gists-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revo-u-a-next-generation-gene-editing-free-universal-car-t-platform-to-enable-ultra-high-yield-man 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cancer-screening-across-disease-sites-for-transgender-and-gender-diverse-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiogenomic-biomarkers-for-identifying-surgery-sparing-candidates-in-locally-advanced-gastric-or-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-survival-outcomes-in-patients-with-multiple-myeloma-and-treatment-facility-volum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-adjuvant-nab-paclitaxel-plus-s-1-after-d2-resection-in-stage-iii-diffuse-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-plus-lenvatinib-and-pd-1-inhibitors-as-first-line-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-biomarkers-of-sensitivity-to-bipolar-androgen-therapy-bat-in-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-hematologic-malignancy-in-patients-with-early-stage-chronic-kidney-disease-ship-ckd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missed-by-the-guidelines-a-meta-analysis-of-uspstf-lung-cancer-screening-ineligibility-among-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-language-barrier-a-mere-proxy-psychological-distress-among-non-english-speaking-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-efficacy-of-a-tailored-exercise-program-in-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-and-cardiovascular-outcomes-of-sglt2-inhibitors-in-patients-with-chronic-lymphocytic-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-acute-myeloid-leukemia-aml-patient-disease-and-molecular-characteristics-with-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-resection-of-cavity-shave-margins-impact-survival-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-an-oral-anticancer-repository-program-and-the-impact-on-access-to-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-external-validation-of-a-computational-approach-for-accelerated-read-out-of-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-incidence-and-mortality-in-lgbtq-populations-compared-with-cisgender-heterosexual-ind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-targeted-tyrosine-kinase-inhibitors-in-breast-cancer-real-world-analysis-of-gastrointestinal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falcon-lung-evolving-global-real-world-treatment-choices-and-outcomes-for-metastatic-nsclc-in-diffe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leisure-time-physical-activity-among-us-cancer-survivors-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-failure-if-as-a-prognostic-marker-in-adult-acute-lymphoblastic-leukemia-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cldn182-targeting-antibody-drug-conjugate-ba1301-in-advanced-solid-tumors-results-from-a-phase-i-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unsupervised-clustering-of-rna-seq-data-to-identify-molecular-subtypes-of-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-alliance-a031902-a-phase-iii-trial-of-enzalutamide-plus-rucaparib-as-first-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-treatment-with-toripalimab-and-anlotinib-after-anthracycline-based-chemotherapy-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-outcomes-of-minimally-invasive-resection-in-patients-with-neuroblastoma-and-wilms-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-serplulimab-combined-with-nab-paclitaxel-and-epirubicin-in-high-risk-early-hrher2-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-lutetium-lu-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-testicular-cancer-burden-among-adolescents-and-young-adults-15-39-years-1990-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-intraoperative-radiotherapy-for-soft-tissue-sarcoma-the-largest-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-benefit-of-doublet-versus-triplet-braf-inhibitor-based-therapy-insights-from-the-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-prmt5-inhibitor-azd3470-in-patients-with-relapsedrefractory-classic-hodgkin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-olaparib-in-us-veterans-with-metastatic-castration-resistant-prostate-cancer-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-by-genomic-profile-in-her2-positive-her2-metastatic-breast-cancer-mbc-a-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-tissue-free-genome-wide-methylome-enrichment-assay-for-detecting-molecular-residual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-1-immunotherapy-with-chemotherapy-for-poorly-chemo-responsive-thyroid-and-salivary-gland-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-dose-finding-study-of-triplet-regimen-of-relatlimab-rela-ipilimumab-ipi-and-nivolum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-related-mortality-across-world-bank-income-groups-1980-2023-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intraoperative-frozen-section-in-detection-and-surgical-decision-making-of-suspected-gallbla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-patterns-in-chimeric-antigen-receptor-t-cell-therapy-hospitalizations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-burden-and-downstream-consequences-of-severe-fluoropyrimidine-associated-toxicity-in-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiovascular-toxicities-with-bispecific-antibody-therapy-in-patients-with-hematolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-racial-and-socioeconomic-factors-on-cutaneous-b-cell-lymphoma-survival-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-polatuzumab-vedotin-targeting-cd79b-in-the-treatment-of-non-hodgkin-lymphoma-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-quality-of-life-in-advanced-lung-cancer-the-role-of-depressive-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cd3cd20-bispecific-antibodies-in-richter-transformation-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-pembrolizumab-plus-paclitaxel-with-or-without-bevacizumab-in-pd-l1-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-managed-with-active-surveillance-versus-treatment-for-prostate-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-stress-phenotypes-as-drivers-of-extreme-inpatient-severity-and-resource-utilization-withou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpreting-circulating-tumor-dna-guided-risk-stratification-after-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metronomic-adjuvant-chemotherapy-mace-in-locally-advanced-oral-cavity-squamous-cell-carcinoma-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-the-next-generation-nectin-4-targeting-antibody-drug-conjugate-crb-701-sys6002-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiotoxicity-with-her2-antibody-drug-conjugates-and-survival-after-treatment-continuati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropsychiatric-symptom-and-biomarker-changes-with-electroacupuncture-in-adolescent-and-young-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-a-short-course-12-week-de-escalated-neoadjuvant-regimen-weekly-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raisic-1-a-phase-12-clinical-trial-of-the-gpr65-inhibitor-ptt-4256-preliminary-safety-tolerabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chrono-a-randomized-phase-ii-trial-of-the-chronology-of-surgery-after-neoadjuvant-chemotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analyses-of-molecular-subsets-and-correlations-with-clinical-outcomes-from-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-mirvetuximab-soravtansine-in-folate-receptor-alpha-fra-high-recurre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-in-vivo-car-t-therapy-gt801-in-adults-with-relapsed-or-refractory-cd19-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-glp-1-receptor-agonist-use-on-lung-cancer-incidence-in-high-risk-patients-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-guided-computational-pathology-model-to-stratify-docetaxel-benefit-in-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyrotinib-plus-nab-paclitaxel-as-adjuvant-therapy-for-patients-with-n0n1mi-her2-positive-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-blood-based-biomarkers-as-early-predictors-of-progression-free-survival-in-a-randomized-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pembrolizumab-or-placebo-plus-chemotherapy-followed-by-adjuvant-pembrolizumab-or-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-cachexia-and-symptomatic-toxicity-among-706-older-adults-with-advanced-cancer-receiving-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/midday-immune-checkpoint-inhibitor-ici-infusion-influence-on-survival-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-restricted-eating-and-metformin-team-in-invasive-breast-cancer-or-dcis-a-randomized-phase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-concomitant-medications-in-advanced-prostate-cancer-patients-receiving-apalutamide-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-fih-phase-i-study-of-gfs202a-a-gdf15il-6-bispecific-antibody-in-advanced-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-korea-usa-multicenter-study-of-duodenal-pancreatic-fluid-derived-exosomal-ces1-and-man2a1-as-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-mogamulizumab-retreatment-in-cutaneous-t-cell-lymphoma-a-single-center-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-sex-based-differences-in-tumor-microenvironments-within-hematopoietic-and-reticuloendoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunochemotherapy-plus-thymalfasin-in-locally-advanced-gastric-cancer-a-prospective-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-toxicity-of-car-t-therapy-versus-blinatumomab-in-adult-b-cell-acute-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pegylated-liposomal-doxorubicin-plus-anlotinib-in-locally-advanced-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-derived-tumor-microenvironment-features-and-recurrence-risk-in-microsatellite-stable-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-assessing-the-efficacy-and-safety-of-mcapox-plus-cetuximab-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-inhibitor-plus-paclitaxel-pingyangmycin-and-platinum-based-chemotherapy-4p-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-machine-learning-to-predict-treatment-delivery-accuracy-in-brain-stereotactic-radiosurgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-landscape-and-real-world-management-of-braf-non-v600e-and-map2k1-alterations-analysis-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-evaluation-of-the-worlds-first-tri-specific-sirpa-pd-1-tgf-v-fc-fusion-prote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-clinical-trial-failure-and-termination-in-non-small-cell-lung-cancer-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-breast-cancer-outcomes-in-the-neoadjuvant-i-spy2-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-organophosphorus-pesticide-residues-in-breast-cancer-tissue-a-translational-integrated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ilt4-on-lipid-metabolism-of-tumor-associated-macrophages-to-drive-immunosuppression-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-comprehensive-genomic-profiling-based-approach-for-homologous-recombination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-comprehensive-genomic-profiling-implementation-in-japan-and-perspectives-on-systemic-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-clinical-follow-up-for-breast-cancer-survivorship-care-a-narrative-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-activity-of-sacituzumab-govitecan-in-her2-negative-breast-cancer-brain-metastases-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-elranatamab-in-patients-with-relapsedrefractory-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-patient-facing-information-on-artificial-intelligence-in-cancer-care-a-cross-sectional-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-harmonized-workflow-to-enable-efficient-tumor-normal-matched-whole-genome-sequencing-from-hmw-gdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atypical-radiologic-response-patterns-in-patients-treated-on-immunotherapy-clinical-trials-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/botensilimab-bot-balstilimab-bal-in-patients-pts-with-advanced-cutaneous-melanoma-cmel-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-b7h3il13ra2-bispecific-armored-car-t-for-treatment-of-recurrentrefractory-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-years-of-metastatic-uveal-melanoma-management-real-world-experience-from-a-comprehensive-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-retrospective-analysis-of-outcomes-treatment-duration-dose-intensity-and-safety-of-enf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-patients-with-mucosal-melanoma-in-the-us-before-and-after-the-advent-of-pd-1-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-year-overall-survival-after-adjuvant-treatment-for-stage-iii-melanoma-an-english-nationwide-regis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-adjuvant-chemoendocrine-versus-endocrine-therapy-alone-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-therapeutic-targets-in-patients-treated-with-immune-checkpoint-inhibitors-for-advanced-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-sequencing-as-a-cutting-edge-technology-to-identify-pathogenic-germline-variants-from-8353-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-versus-no-adjuvant-therapy-after-major-pathological-response-to-neoadjuvant-immunotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-use-among-women-lt-50-years-with-node-negative-early-stage-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-18f-labeled-glutamine-pet-radiotracer-to-detect-serine-synthesis-pathway-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-profile-treatment-patterns-and-survival-outcomes-of-multiple-myeloma-patients-in-the-midd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-coaching-in-enhancing-clinical-oncology-academic-performance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inulin-on-immunotherapy-efficacy-in-extensive-stage-small-cell-lung-cancer-and-on-promotio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-clinical-impact-of-temozolomide-induced-hepatotoxicity-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-differentiated-sirpa-igg4-fc-fusion-protein-hcb101-in-monotherapy-and-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-trial-of-adagloxad-simoleninobi-821-in-patients-with-high-risk-early-stage-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-small-cell-carcinoma-with-fusiform-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-early-onset-renal-cell-carcinoma-by-metastatic-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/light-activated-egfr-antibody-drug-conjugate-analysis-of-selectivity-and-translational-profile-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-spatial-immune-architecture-and-1-year-clinical-benefit-to-first-line-icb-in-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-treatment-related-outcomes-with-folfirinox-compared-with-gemcitabinenab-paclit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-functional-outcomes-in-octogenarians-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-era-of-immunotherapy-comparison-of-real-world-outcomes-in-limited-stage-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-ivonescimab-and-chemotherapy-as-first-line-1l-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-post-treatment-vaginal-structural-changes-with-psychosexual-dysfunction-in-young-cerv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-biomarker-profiling-in-patients-with-non-small-cell-lung-cancer-and-leptomeninge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-information-received-and-perceived-by-patients-with-metastatic-breast-cancer-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-toxicity-profile-of-chimeric-antigen-receptor-t-cell-therapy-versus-bispecific-t-cell-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practice-patterns-and-outcomes-by-genomic-risk-in-octogenarians-with-high-risk-localized-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sources-matter-learning-to-evaluate-large-language-models-for-oncology-treatment-plans-and-changes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-overall-survival-os-with-imetelstat-ime-in-relapsedrefractory-rr-myelofi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-recombinant-bcg-combined-with-chemo-immunotherapy-chemo-io-as-perioperative-therapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-tp53-mutation-acquisition-as-a-determinant-of-outcomes-in-patients-with-myeloproliferative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-expedited-cancer-workup-clinic-for-uninsured-patients-at-a-metropolitan-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-ibi310-combined-with-sintilimab-versus-sorafenib-in-the-first-line-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-in-the-post-immunotherapy-era-does-second-line-tyrosine-kinase-inhibitor-choice-impact-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-surgery-improve-breast-cancer-specific-survival-in-low-grade-dcis-a-20-year-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/commercial-price-variation-in-precision-oncology-testing-across-us-hospitals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tisle-combined-with-pofi-irinotecan-paclitaxel-oxaliplatin-and-5-fulevoleucovori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-surgery-on-survival-outcomes-in-korean-breast-cancer-patients-a-nationwide-popula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vessel-branching-patterns-quantified-by-artificial-intelligence-as-a-novel-prognostic-biomarker-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-emavusertib-ca-4948-in-combination-with-gemcitabine-and-nab-paclitaxel-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-immune-checkpoint-inhibitors-among-patients-with-cancer-from-minoritized-raci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-safety-and-efficacy-results-from-three-clinical-studies-evaluating-alpha-radiotherapy-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-patient-facing-app-to-address-surgical-oncology-patients-social-determinants-of-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficacy-of-intrathecal-pd-1-blockade-combined-with-whole-brain-radiotherapy-for-melanom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-progression-defined-by-longitudinal-ctdna-dynamics-for-prediction-of-outcomes-in-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-treatment-delay-matter-impact-of-time-to-immunotherapy-on-survival-in-extensive-stage-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-site-specific-spectrum-of-second-primary-malignancies-after-adult-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-inpatient-outcomes-and-hospital-volume-disparities-after-glioma-resection-a-hcup-nis-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-ierbb2i-gene-amplification-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-frozen-sections-for-intraoperative-detection-of-spread-through-air-spaces-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-high-body-mass-index-on-cancer-mortality-in-the-united-states-an-emerging-public-heal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-fibroblast-growth-factor-receptor-2-fgfr2-fusions-mutations-and-amplifications-in-intrahep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dxc006-a-first-in-class-cd56-targeting-antibody-drug-conjugate-in-advanced-solid-tumors-a-first-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-artificial-intelligence-for-automated-prognostication-and-systemic-therapeutic-dec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-stage-validation-of-a-multimodal-machine-learning-model-to-predict-pathological-complete-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-anti-cancer-treatment-rx-patterns-in-patients-pts-with-the-six-most-common-cancers-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-and-dostarlimab-in-locally-advanced-head-and-neck-squamous-cell-carcinoma-la-hnscc-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-an-open-label-single-arm-phase-23-trial-spark-all-of-calaspargase-pegol-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-clinical-study-of-adebrelimab-combined-with-decitabine-nab-paclitaxel-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-insights-into-survival-outcomes-and-unmet-therapeutic-needs-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-prediction-of-cardiovascular-mortality-in-gynecologic-cancer-survivors-using-machin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-telomere-length-and-prediction-of-cognitive-recovery-after-chemotherapy-in-patients-with-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacogenetic-pgx-markers-of-cardiovascular-side-effects-cvses-in-allogeneic-hematopoietic-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/k-accelerate-a-multi-center-prospective-trial-to-evaluate-the-utility-of-a-ctdna-based-assay-for-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-outcomes-of-darolutamide-and-androgen-deprivation-therapy-in-patient-subgr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-geospatial-oncologist-placement-a-maximum-coverage-problem-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-mortality-patterns-and-treatment-disparities-of-prostate-cancer-across-g20-countries-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sociodemographic-environmental-and-health-factors-with-early-onset-cancer-in-a-dive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-post-apt-trial-adoption-of-de-escalated-systemic-therapy-and-outcomes-in-small-her2-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-access-to-chimeric-antigen-receptor-t-cell-car-t-therapy-post-leukapheresis-waiting-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-multimorbidity-related-mortality-among-patients-with-lung-cancer-and-hypertensiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/danis-3-a-phase-ii-platform-study-of-nis793-and-anti-pd-1-combined-with-standard-of-care-soc-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-uveal-melanoma-genomic-landscape-and-immunogenic-profiles-of-ignaqi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-ctdna-release-influencing-factors-in-luminal-breast-cancer-via-single-cell-spatial-mappi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-recommendation-after-breast-conserving-surgery-for-er-ductal-carcinoma-in-situ-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-plasma-and-csf-ctdna-profiling-as-used-to-define-therapeutic-landmarks-and-compartmenta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-survival-of-4n-and-non-4n-metastatic-neuroblastoma-across-treatment-eras-a-repo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bayonet-trial-a-multicenter-phase-ii-trial-of-staged-combination-with-encorafenib-binimetinib-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-outcomes-of-metastatic-triple-negative-breast-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvantadjuvant-serplulimab-vs-placebo-combined-with-chemotherapy-for-pd-l1-positive-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-axl-expression-in-upper-gastrointestinal-cancer-in-monstar-screen-2-an-interna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-studying-integrative-palliative-care-in-a-community-oncology-practice-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-her2-targeted-nir-ii-fluorescent-nanoprobe-for-precision-diagnosis-and-treatment-of-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-weight-of-each-node-modeling-and-quantifying-breast-cancer-lymphedema-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-real-world-progression-free-survival-and-time-to-next-treatment-and-death-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-implementation-of-evidence-based-depression-and-distress-treatment-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-hb-200-in-patients-with-hpv16-head-and-neck-squamous-cell-carcinoma-and-detectable-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-human-papillomavirus-hpv-vaccination-on-cervical-cancer-risk-reduction-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-stage-iv-primary-extramammary-paget-disease-a-systematic-review-of-reported-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-prognostic-factors-in-luminal-a-luma-early-breast-cancer-ebc-real-world-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-lymph-node-yield-and-survival-after-neoadjuvant-immunotherapy-for-head-and-neck-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-of-breast-cancer-warning-signs-and-risk-factors-and-their-association-with-stage-at-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-characterization-of-high-tumor-mutational-burden-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-hrd-phenotyping-as-a-predictor-of-parp-inhibitor-benefit-in-first-line-maintenance-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-inequities-in-ovarian-cancer-care-a-national-study-of-hospital-utilization-costs-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-immune-checkpoint-inhibitors-in-patients-with-advanced-sarcomas-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-biomarker-intended-pembrolizumab-use-in-soft-tissue-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scanxiety-patient-experience-of-immediate-result-release-irr-of-cancer-related-imaging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-eligibility-and-reporting-standards-for-older-patients-with-hormone-receptor-positive-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-site-and-diagnostic-pathway-on-stage-at-diagnosis-a-population-based-study-of-5638 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-indicators-and-socioeconomic-disparities-in-teratoma-with-malignant-transformation-an-nc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-resilience-and-financial-toxicity-the-role-of-age-education-and-health-insura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ggpp-as-a-driver-of-esophageal-squamous-cell-carcinoma-progression-via-protein-prenylation-therapeu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-study-evaluating-cetuximab-super-responders-with-recurrent-or-metastatic-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-outpatient-multidisciplinary-model-for-care-of-immune-related-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arrhythmic-outcomes-following-immune-checkpoint-inhibitor-ici-therapy-in-patients-with-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetes-related-mortality-among-cancer-survivors-a-population-based-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-maintenance-therapy-in-unresectable-locally-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volumetric-analysis-of-central-nervous-system-hemangioblastomas-during-belzutifan-treatment-holiday 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chatgpt-based-conversational-ai-tool-for-training-oncologists-in-patient-communication-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-presentation-and-inpatient-vulnerability-in-sinonasal-malignancies-national-evidence-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ovarian-function-suppression-use-among-premenopausal-women-with-breast-cancer-a-longitudi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-acute-care-utilization-and-clinical-outcomes-among-patients-with-lung-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-neoadjuvant-versus-adjuvant-chemotherapy-in-stage-ii-iii-hormone-receptor-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-after-neoadjuvant-chemotherapy-in-triple-negative-invasive-lobular-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-the-diagnostic-value-of-micrornas-for-early-colorectal-cancer-detection-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-prevalence-of-antibody-drug-conjugated-induced-nausea-and-vomiting-adcinv-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triombm-a-multicenter-phase-ii-trial-of-relatlimab-nivolumab-and-ipilimumab-in-patients-with-asy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flt3-inhibitors-in-acute-myeloid-leukemia-a-network-meta-analysis-of-phase-iii-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-the-tcf7l2-rs7903146-t-allele-in-young-hispanic-adults-implications-for-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ep0062-vosilasarm-a-first-in-class-oral-selective-androgen-receptor-modulato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-complications-in-car-t-cell-therapy-insights-from-a-national-inpatient-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-quantification-of-laryngeal-motion-in-early-glottic-cancer-using-mr-linac-cine-imaging-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ablation-success-and-long-term-recurrence-with-low-dose-versus-high-dose-radioiodine-for-remnant-thy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-pan-cancer-foundation-model-for-digital-patient-representation-and-clinical-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-exposure-with-mortality-infectious-and-hematologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-and-cardiovascular-outcomes-after-hematopoietic-cell-transplantation-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-multicenter-open-label-dose-escalation-and-expansion-study-to-evaluate-the-safety-tole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-logic-gated-chimeric-antigen-receptor-t-cell-car-t-therapy-with-an-armored-membrane-tethered-il 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-of-osteopenia-in-adult-non-metastatic-gastrointestinal-cancer-patients-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-non-receipt-of-fertility-counseling-during-cervical-cancer-treatment-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-and-health-expenditures-among-us-adults-by-cancer-and-atherosclerotic-cardi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-oxaliplatin-plus-s-1-versus-docetaxel-plus-s-1-for-stage-iii-gastric-cancer-after-d2-gastre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-tislelizumab-vs-trifluridinetipiracil-and-bevacizumab-in-mss-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-socioeconomic-prognostic-factors-in-chronic-lymphocytic-leukemia-with-normal-fish 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-004-phase-3-trial-of-the-steroidogenesis-inhibitor-opevesostat-versus-androgen-receptor-pathw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adela-a-double-blind-placebo-controlled-randomized-phase-3-trial-of-elacestrant-ela-everolimu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-outcomes-for-steroid-refractory-immune-related-hepatotoxicity-in-locally-advanced-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plastic-and-single-use-materials-in-breast-cancer-screening-and-diagnosis-a-multi-center-audit-of-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-complications-as-a-major-driver-of-icu-utilization-in-hospitalized-cancer-patients-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/highlight-1-a-randomized-placebo-controlled-double-blind-phase-3-clinical-study-to-investigate-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-ivonescimab-for-previously-treated-thymic-carcinoma-ucla-l-11 2026-08-24 monthly 0.7 https://rjrindex.com/articles/condensate-driven-transcriptional-reprogramming-to-define-core-vulnerabilities-in-esophageal-and-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teliso-v-monotherapy-and-egfr-tki-combinations-in-c-met-over-expressing-nsclc-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-system-gaps-in-access-to-her2-directed-chemotherapy-in-early-stage-her2-positive-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-toxicity-and-temporal-mortality-patterns-following-bispecific-t-cell-engager-therapy-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncoupling-of-mt1e-transcription-and-translation-in-high-cna-colorectal-cancer-a-proteostatic-adapt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-in-colorectal-cancer-incidence-prevalence-and-mortality-burden-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metric-indicators-of-lymphedema-and-their-impact-on-symptoms-and-quality-of-life-in-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-isg15-as-predictor-of-outcome-from-antiangiogenic-therapy-in-solitary-fibrous-tumor-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-social-capital-and-cancer-screening-rates-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-iota-input-optimization-for-tissue-based-assays-improving-turnaround-time-tat-of-mutati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-landscape-and-future-directions-of-breast-cancer-screening-and-early-detection-of-disease-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-vitamin-d-levels-with-survival-and-disease-control-in-diffuse-large-b-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-non-hodgkin-lymphoma-in-south-asia-1990-2023-analysis-of-the-global-burden-of-disease-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-mycosis-fungoides-outcomes-a-multivariate-survival-and-prevalence-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genitourinary-safety-of-sglt2-inhibitors-in-patients-with-cancer-and-type-2-diabetes-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profile-and-clinical-outcomes-of-patients-with-thoracic-tumors-discussed-at-a-tumor-board-in-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistent-and-divergent-cervical-cancer-burden-in-sub-saharan-africa-1990-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-determinants-of-overall-survival-in-early-onset-head-and-neck-cancers-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-on-outcomes-of-zanidatamab-plus-chemotherapy-in-patients-with-advanced-her2-gastroes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-arv-393-a-protac-bcl6-degrader-as-monotherapy-in-patients-with-advanced-non-hodgk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/silver-supplementing-tebentafusp-with-subcutaneous-il-2-to-verifiably-eradicate-radiological-progre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-results-from-duravelo-2-zelenectide-pevedotin-zele-bt8009-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-a-deep-learning-based-serial-ct-imaging-biomarker-with-variable-thoracic-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redox-status-of-endometrial-tumors-a-comparative-study-in-endometrioid-adenocarcinoma-serous-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modern-concepts-of-endometrial-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemoradiotherapy-versus-radiotherapy-alone-in-high-risk-endometrial-cancer-updated-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergence-between-progression-free-and-overall-survival-treatment-effect-sizes-in-antibody-drug-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibition-with-camrelizumab-in-cervical-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-osteopenia-osteoporosis-and-pathological-fractures-in-breast-cancer-patients-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-immune-toxicity-and-treatment-outcomes-in-triple-negative-breast-cancer-treated-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-clinical-validation-of-a-novel-integrated-genomic-and-epigenomic-liquid-biopsy-assay-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-susceptibility-between-psychiatric-disorders-and-gynecologic-cancers-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-spatial-multiomics-to-identify-endosomal-trafficking-and-s100a8a9-and-fibronectin-driven-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refusal-of-chemotherapy-surgery-and-radiation-in-non-metastatic-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-telehealth-experiences-medication-adherence-symptom-burden-and-financial-toxicit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adoption-in-triple-negative-breast-cancer-through-community-based-quality-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-non-melanoma-skin-cancer-related-hospitalizations-and-in-hospital-outcomes-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-mental-health-disorders-modify-cytokine-release-syndrome-risk-in-immune-effector-cell-therapy-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-and-resource-utilization-with-an-icd-10-defined-immune-related-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-safety-planning-in-nccn-cited-breast-cancer-trials-audit-and-surveillance-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-based-differences-in-malnutrition-among-patients-with-stage-iv-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-in-mantle-cell-lymphoma-patients-treated-with-car-t-therapy-a-real-world-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-inpatient-treatment-delivery-for-gynecologic-cancers-a-national-analysis-using-machi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hetrombopag-in-patients-with-chemotherapy-induced-thrombocytopenia-a-global-phase-3-randomized-do 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-axicabtagene-ciloleucel-in-older-versus-younger-adults-with-diffuse-large-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-inpatient-ip-systemic-cancer-therapy-in-patients-pts-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-higher-initial-dose-and-accelerated-titration-of-ropeginterferon-alfa-2b-on-early-hematolo 2026-08-24 monthly 0.7